Carfilzomib is an Epoxykeytone Proteasome Inhibitor for Multiple Myeloma Research
Multiple Myeloma (MM) is characterized by the production of monoclonal immunoglobulin (Ig), which may be detected in serum or urine, and tumor cell tropism for the bone marrow (BM). Carfilzomib…